MedPath
TGA Approval

SERENACE haloperidol 20 mg/2 mL injection ampoule (10260)

10260

SERENACE haloperidol 20 mg/2 mL injection ampoule

Aspen Pharmacare Australia Pty Ltd

August 30, 1991

Medicine

Medicine

Active

Registered

Product Information

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-PI-02397-1

Active Ingredients

haloperidol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.